Regencell Bioscience Holdings Limited
RGCNASDAQ · Healthcare · Drug Manufacturers - Specialty & GenericRegencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company.
$5.27-2.77%
报价 2026-11-06
市值
$2.61B
EV
$3.11B
PE (TTM)
–
预期 PE
–
52 周区间距高点 -90.0%
$4.78$52.88
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
does not hit growth, cheap, or GARP pool
研究结论
L2 2026-07-01全文 ↓尚未生成 L3 估值，没有三情景目标价。去生成估值 →
L2 报告格式无法提取要点，请看全文。
历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
同行业市值相近 · Drug Manufacturers - Specialty & Generic| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| RGCRegencell Bioscience Holdings Limited | $2.61B | -2.8% | – | 0% | – | – | – | |
| BHCBausch Health Companies Inc. | $3.06B | +2.8% | +7.5% | 75% | – | 8.9x | 1.7x | |
| HCMHutchison China Ltd. | $2.64B | +6.8% | +10.9% | 17% | 145.0x | – | 234.4x | |
| PRGOPerrigo Company plc | $2.2B | +0.9% | -6.0% | 30.7% | – | – | 12.9x | |
| TRLVTrulieve Cannabis Corp. | $1.97B | +6.1% | -15.1% | 59.9% | – | 6.8x | 8.2x | |
| ALVOAlvotech | $1.73B | +6.8% | +1.1% | 50.7% | – | – | – | |
| ANIPANI Pharmaceuticals, Inc. | $1.55B | -3.2% | +27.2% | 61.6% | 13.0x | 5.3x | 8.1x | Cheap GARP |
| SUPNSupernus Pharmaceuticals, Inc. | $1.52B | -2.2% | +25.9% | 85.7% | 7.1x | 3.0x | 49.1x | Cheap GARP |
| PCRXPacira BioSciences, Inc. | $1.45B | +0.0% | +3.3% | 77% | 103.2x | 14.4x | 8.1x | |
| 同行中位数 | – | – | +5.4% | 60.8% | 58.1x | 6.8x | 8.2x |
研究全文
财务报表
| Metric | 2026-06-30 Q4 2026 | 2025-12-31 Q2 2026 | 2025-06-30 Q4 2025 | 2024-12-29 Q2 2025 | 2024-06-30 Q4 2024 | 2023-12-30 Q2 2024 | 2023-06-30 Q4 2023 | 2022-12-30 Q2 2023 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross Margin | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Operating Margin | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | $-6.4M | $-5.3M | $-1.7M | $-1.9M | $-1,117 | $-1,033 | $-2.6M | $-3.2M |
| Diluted EPS | -0.01 | -0.01 | -0 | -0 | -0 | -0 | -0.01 | -0.01 |
| Operating Cash Flow | $-5.1M | $-2.6M | $0 | $0 | $-2M | $-2M | $-2.5M | $-2.5M |